Dry Eye Disease Treatment Market to Witness an Outstanding
Global Chronic
Eye Diseases Market, Type (Diabetic and Hypertensive Retinopathy,
Cataracts, Age-Related Macular Degeneration (AMD), Thyroid Ophthalmopathy
(Grave’s Disease), Glaucoma Dry Eye, Others), Medication (Anti-inflammatory,
Anti-glaucoma, Lubricating Agents, Immunosuppressive, Others), Product Type
(Eye Drops, Eye Ointment, Gel, Liquid Wipes, Others), Route of Administration (Oral, Parenteral,
Ocular, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others),
Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy,
Others) – Industry Trends and Forecast to 2029
Market
Analysis and
Size
According
to estimates, over 9% of the global population is over 65 years old, with this
segment predicted to account for around 17% of the global population by 2050.
Age-related eye problems such as age-related macular degeneration, cataract,
diabetic retinopathy, and glaucoma are the most common causes of blindness and
impaired vision in the United States. Amblyopia and strabismus are two more
frequent eye ailments.
Data
Bridge Market Research analyses that the chronic eye diseases market was valued
at USD 20.828 million in 2021 and is expected to reach USD 33.96 million by
2029, registering a CAGR of 6.30% during the forecast period of 2022 to 2029.
In addition to the market insights such as market value, growth rate, market
segments, geographical coverage, market players, and market scenario, the
market report curated by the Data Bridge Market Research team also includes
in-depth expert analysis, patient epidemiology, pipeline analysis, pricing
analysis, and regulatory framework.
Market
Definition
Chronic
eye diseases can be caused by a variety of factors, including bacterial,
fungal, and allergic infection, tissue dryness due to excessive contact lens
use, repeated rubbing of the eyes and eye makeup, and hereditary and
metabolic processes. Patients with eye ailments may experience redness and
inflammation, as well as dryness, blurred vision, swelling, discomfort and
soreness, watery eyes, and other symptoms.
Chronic Eye Diseases
Market Dynamics
·
High prevalence rate of diabetes
and other chronic conditions
The
rising prevalence of diabetes across the globe will act as a major
driver that will result in the expansion of the growth rate of the market.
According to the American Optometric Association, there are over 7 million
undiagnosed diabetes in the United States, with 12,000 to 24,000 people losing
their sight each year. Diabetic retinopathy is currently the most common cause
of blindness in the United States. Diabetic patients must get a dilated eye
check every year. Diabetic problems such as blindness and other complications
can be avoided by keeping an eye on retinal abnormalities. Along with this,
prevalence of various disease such as cataracts, glaucoma and age-related
macular degeneration will act as the market growth factor.
·
Increasing investment for healthcare infrastructure
·
Increasing number of geriatric population
Request Access for
Chronic Eye
Diseases Market Sample
Report:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-chronic-eye-diseases-market
Opportunities
·
Rise in R&D activities
The market's growth is fueled by growing number of research
and development activities. This will provide beneficial opportunities for the
chronic eye diseases market growth. New entrants are focusing on creating new
steroid-based formulations to treat dry eye syndrome (DES), which is also a major driving element in the
market
Restraints/Challenges
On the other hand, the high cost associated with
the treatment will obstruct the growth rate of chronic eye diseases market
during the forecast period of 2022-2029. The lack of healthcare infrastructure
in developing economies and strict drug approval mechanisms of testing bodies
resulted in the delay of launch of new drugs will challenge the chronic eye
diseases market. Additionally, lack of awareness among people and poor reimbursement
policies will act as restrain and further impede the growth rate of market
during the forecast period of 2022-2029.
Patient Epidemiology Analysis
Chronic eye diseases market also provides you with
detailed market analysis for patient analysis, prognosis and cures. Prevalence,
incidence, mortality, adherence rates are some of the data variables that are
available in the report. Direct or indirect impact analyses of epidemiology to
market growth are analysed to create a more robust and cohort multivariate
statistical model for forecasting the market in the growth period.
Global Chronic Eye
Diseases Market Scope
The
chronic eye diseases market is segmented on the basis of type, medication,
product type, route of administration, end-users and distribution channel. The
growth amongst these segments will help you analyze meagre growth segments in
the industries and provide the users with a valuable market overview and market
insights to help them make strategic decisions for identifying core market
applications.
Type
·
Diabetic and Hypertensive Retinopathy
·
Cataracts
·
Age-Related Macular Degeneration (AMD)
·
Thyroid Ophthalmopathy (Grave’s Disease)
·
Glaucoma Dry Eye
·
Others
Medication
·
Anti-inflammatory
·
Anti-glaucoma
·
Lubricating Agents
·
Immunosuppressive
·
Others
Product Type
·
Eye Drops
·
Eye Ointment
·
Gel
·
Liquid Wipes
·
Others
Route of Administration
·
Oral
·
Parenteral
·
Ocular
·
Others
End-Users
·
Hospitals
·
Specialty Clinics
·
Homecare
·
Others
Distribution Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
·
Others
Competitive Landscape
and Chronic Eye Diseases Market Share Analysis
The
chronic eye diseases market competitive landscape provides details by
competitor. Details included are company overview, company financials, revenue
generated, market potential, investment in research and development, new market
initiatives, global presence, production sites and facilities, production
capacities, company strengths and weaknesses, product launch, product width and
breadth, application dominance. The above data points provided are only related
to the companies' focus related to chronic eye diseases market.
Some
of the major players operating in the chronic eye diseases market are:
·
Eli Lilly and Company (U.S.)
·
AstraZeneca (U.K.)
·
Novartis AG (Switzerland)
·
Johnson & Johnson Private Limited (U.S.)
·
Teva Pharmaceutical Industries Ltd. (Ireland)
·
Merck & Co., Inc. (U.S.)
·
Allergan (Ireland)
·
Bausch Health Companies Inc. (Canada)
·
Abbott (U.S.)
·
F. Hoffmann-La Roche Ltd. (Switzerland)
·
Pfizer Inc. (U.S.)
·
GlaxoSmithKline plc (U.K.)
·
Sanofi (France)
·
Merck KGaA (Germany)
·
Otsuka America Pharmaceutical, Inc. (U.S.)
·
Akorn Operating Company LLC (U.S.)
·
Allostera Pharma Inc. (Canada)
·
I-Med Pharma Inc. (Canada)
·
Santen Pharmaceuticals Co. Ltd., (Japan)
·
AFT Pharmaceuticals (New Zealand)
·
Novaliq GmbH (Germany)
Customization Available
Data Bridge Market Research is a leader in advanced
formative research. We take pride in servicing our existing and new customers
with data and analysis that match and suits their goal. The report can be
customized to include price trend analysis of target brands understanding the
market for additional countries (ask for the list of countries), clinical trial
results data, literature review, refurbished market and product base analysis.
Market analysis of target competitors can be analyzed from technology-based
analysis to market portfolio strategies. We can add as many competitors that
you require data about in the format and data style you are looking for. Our
team of analysts can also provide you data in crude raw excel files pivot
tables (Factbook) or can assist you in creating presentations from the data
sets available in the report.
Access Full Report :- https://www.databridgemarketresearch.com/reports/global-chronic-eye-diseases-market
MAJOR TOC OF THE
REPORT
- INTRODUCTION
- MARKET SEGMENTATION
- MARKET OVERVIEW
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- Chronic Eye Diseases
Market
- COMPANY PROFILE
- COMPONENT MANUFACTURER
- CONCLUSION
- QUESTIONNAIRE
- RELATED REPORTS
Get TOC of the Report : https://www.databridgemarketresearch.com/toc/?dbmr=global-chronic-eye-diseases-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
Comments
Post a Comment